HCID 20671782, compound → HCID 86757170, compound
Reaction equation
[CH3:1][N:2]1[C@H:6]([C:7]2[CH:12]=[CH:11][C:10]([C:13]#[N:14])=[CH:9][CH:8]=2)[CH2:5][C@H:4]([CH2:15][C:16]([OH:18])=[O:17])[O:3]1.[C:19](OC(=N)N(C(C)C)C(C)C)([CH3:22])([CH3:21])[CH3:20]>C(Cl)Cl.Cl[Cu]>[CH3:1][N:2]1[C@H:6]([C:7]2[CH:12]=[CH:11][C:10]([C:13]#[N:14])=[CH:9][CH:8]=2)[CH2:5][C@H:4]([CH2:15][C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[O:3]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of [2-methyl-3(S)-(4-cyanophenyl)-isoxazolidin-5(R)-yl]acetic acid (480 mg, 1.95 mmol) in CH2Cl2 (30 ml) cooled in an ice-water bath was added a 1.6M solution of O-tert-butyl-N, N-diisopropylisourea, cat. CuCl (3.7 ml). The resulting mixture was stirred at rt for 48 hrs. After filtration, the fitrate was concentrated in EtOAc and the residue dissolved in EtOAc. The EtOAc solution was washed with brine and then dried over Na2SO4. After contration, the residue was chromatographed with a mixture of EtOAc and hexane to afford 550 mg of the product as a white solid (93%). 1H NMR (300 MHz, CDCl3) δ1.44(s, 9H), 1.98(m, 1H), 2.50(dd, 1H), 2.60(s, 3H), 2.80(dd, 1H), 2.98(dt, 1H), 3.70(t, 1H), 4.64(m, 1H), 7.50(d, 2H0, 7.66(d, 2H); MS(ESI) Calc. for (M+1)+: 303. Found: 303.
Workup
- filtrationAfter filtration
- concentrationthe fitrate was concentrated in EtOAc
- dissolutionthe residue dissolved in EtOAc
- washThe EtOAc solution was washed with brine
- dry with materialdried over Na2SO4
- customAfter contration, the residue was chromatographed with a mixture of EtOAc and hexane
Sources & evidence
- ORD record
- ord-bf7d8ab3189b4e709ac22db2e258da80
- Source dataset
- uspto-grants-2001_07
- Patent number
- US06265400B1
Reaction notes
Loading…